Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPAT: Oral vs Parenteral Antibiotics
NCT05977868Phase 4Terminated
- Sponsor
- West Virginia University
- Start
- Aug 2023
- Primary completion
- Feb 2025
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin, amoxicillin + clavulanate, cefadroxil, cefpodoxime, cefalexin in vascular infection (VGI), Bone and osteoarticular infections (BJI), skin and soft tissue infection (SSTI), pulmonary infection, gastrointestinal infection, sponsored by West Virginia University. Started Aug 2023; status: terminated.
02
Drugs
amoxicillinamoxicillin + clavulanatecefadroxilcefpodoximecefalexin
03
Conditions
vascular infection (VGI)Bone and osteoarticular infections (BJI)skin and soft tissue infection (SSTI)pulmonary infectiongastrointestinal infection
Beyond the preview
Go deeper on NCT05977868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05977868.